PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf4g
|
ENSMUSG00000017688.15 | Hnf4g |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hnf4g | mm39_v1_chr3_+_3573084_3573129 | 0.24 | 4.5e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_8027640 | 40.92 |
ENSMUST00000171271.8
ENSMUST00000037811.13 |
Apob
|
apolipoprotein B |
chr9_-_46146558 | 34.40 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr12_+_8027767 | 29.47 |
ENSMUST00000037520.14
|
Apob
|
apolipoprotein B |
chr7_-_105249308 | 28.79 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr10_-_24803336 | 28.07 |
ENSMUST00000020161.10
|
Arg1
|
arginase, liver |
chr9_-_103165423 | 27.93 |
ENSMUST00000123530.8
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr16_+_22710785 | 27.18 |
ENSMUST00000023583.7
ENSMUST00000232098.2 |
Ahsg
|
alpha-2-HS-glycoprotein |
chr12_-_103829810 | 27.07 |
ENSMUST00000085056.8
ENSMUST00000072876.12 ENSMUST00000124717.2 |
Serpina1a
|
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
chr12_-_103739847 | 26.83 |
ENSMUST00000078869.6
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr12_-_103704417 | 26.65 |
ENSMUST00000095450.11
ENSMUST00000187220.2 |
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chr2_+_172994841 | 26.48 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr10_-_127724557 | 26.10 |
ENSMUST00000047199.5
|
Rdh7
|
retinol dehydrogenase 7 |
chr19_-_44017637 | 25.99 |
ENSMUST00000026211.10
ENSMUST00000211830.2 |
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr3_+_59939175 | 25.34 |
ENSMUST00000029325.5
|
Aadac
|
arylacetamide deacetylase |
chr6_+_141575226 | 24.96 |
ENSMUST00000042812.9
|
Slco1b2
|
solute carrier organic anion transporter family, member 1b2 |
chr19_-_39875192 | 24.89 |
ENSMUST00000168838.3
|
Cyp2c69
|
cytochrome P450, family 2, subfamily c, polypeptide 69 |
chr19_+_39275518 | 24.86 |
ENSMUST00000003137.15
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr4_+_141473983 | 24.57 |
ENSMUST00000038161.5
|
Agmat
|
agmatine ureohydrolase (agmatinase) |
chr6_-_142418801 | 24.53 |
ENSMUST00000032371.8
|
Gys2
|
glycogen synthase 2 |
chr13_-_55574596 | 24.51 |
ENSMUST00000021948.15
|
F12
|
coagulation factor XII (Hageman factor) |
chr6_+_71176811 | 23.97 |
ENSMUST00000067492.8
|
Fabp1
|
fatty acid binding protein 1, liver |
chr14_-_55995912 | 23.35 |
ENSMUST00000001497.9
|
Cideb
|
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B |
chr19_+_4036562 | 23.34 |
ENSMUST00000236224.2
ENSMUST00000236510.2 ENSMUST00000237910.2 ENSMUST00000235612.2 ENSMUST00000054030.8 |
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr11_-_77784922 | 23.26 |
ENSMUST00000017597.5
|
Pipox
|
pipecolic acid oxidase |
chr8_+_105460627 | 23.02 |
ENSMUST00000034346.15
ENSMUST00000164182.3 |
Ces2a
|
carboxylesterase 2A |
chr13_-_93774469 | 22.78 |
ENSMUST00000099309.6
|
Bhmt
|
betaine-homocysteine methyltransferase |
chr4_+_20008357 | 22.28 |
ENSMUST00000117632.8
ENSMUST00000098244.2 |
Ttpa
|
tocopherol (alpha) transfer protein |
chr9_-_46146928 | 22.20 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr16_+_22713593 | 21.66 |
ENSMUST00000232674.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr15_-_82678490 | 21.62 |
ENSMUST00000006094.6
|
Cyp2d26
|
cytochrome P450, family 2, subfamily d, polypeptide 26 |
chr4_-_115353326 | 21.06 |
ENSMUST00000030487.3
|
Cyp4a14
|
cytochrome P450, family 4, subfamily a, polypeptide 14 |
chr9_-_103165489 | 20.91 |
ENSMUST00000035163.10
|
1300017J02Rik
|
RIKEN cDNA 1300017J02 gene |
chr13_-_55574582 | 20.77 |
ENSMUST00000170921.2
|
F12
|
coagulation factor XII (Hageman factor) |
chr16_+_37400500 | 20.72 |
ENSMUST00000160847.2
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr3_-_157630690 | 20.48 |
ENSMUST00000118539.2
|
Cth
|
cystathionase (cystathionine gamma-lyase) |
chr16_+_37400590 | 20.30 |
ENSMUST00000159787.8
|
Hgd
|
homogentisate 1, 2-dioxygenase |
chr17_+_25097199 | 20.16 |
ENSMUST00000050714.8
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr15_+_10224052 | 20.10 |
ENSMUST00000128450.8
ENSMUST00000148257.8 ENSMUST00000128921.8 |
Prlr
|
prolactin receptor |
chr19_+_12610668 | 20.04 |
ENSMUST00000044976.12
|
Glyat
|
glycine-N-acyltransferase |
chr3_+_57332735 | 19.81 |
ENSMUST00000029377.8
|
Tm4sf4
|
transmembrane 4 superfamily member 4 |
chr10_+_76411474 | 19.33 |
ENSMUST00000001183.8
|
Ftcd
|
formiminotransferase cyclodeaminase |
chr11_-_5865124 | 19.16 |
ENSMUST00000109823.9
ENSMUST00000109822.8 |
Gck
|
glucokinase |
chr16_+_22710134 | 19.04 |
ENSMUST00000231328.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr16_+_22738987 | 18.99 |
ENSMUST00000023587.12
|
Fetub
|
fetuin beta |
chr15_+_82336535 | 18.77 |
ENSMUST00000089129.7
ENSMUST00000229313.2 ENSMUST00000231136.2 |
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr6_+_124470053 | 18.68 |
ENSMUST00000049124.10
|
C1rl
|
complement component 1, r subcomponent-like |
chr2_-_25390625 | 18.60 |
ENSMUST00000040042.11
|
C8g
|
complement component 8, gamma polypeptide |
chr16_-_21606546 | 18.50 |
ENSMUST00000023559.7
|
Ehhadh
|
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
chr7_+_119773070 | 18.30 |
ENSMUST00000033201.7
|
Anks4b
|
ankyrin repeat and sterile alpha motif domain containing 4B |
chr8_+_13087805 | 18.21 |
ENSMUST00000128418.8
ENSMUST00000152034.2 |
F10
|
coagulation factor X |
chr7_-_12732067 | 18.15 |
ENSMUST00000032539.14
ENSMUST00000120903.8 |
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr10_-_75633563 | 18.14 |
ENSMUST00000139724.3
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr19_-_40062174 | 18.09 |
ENSMUST00000048959.5
|
Cyp2c54
|
cytochrome P450, family 2, subfamily c, polypeptide 54 |
chr9_+_108216466 | 17.54 |
ENSMUST00000193987.2
|
Gpx1
|
glutathione peroxidase 1 |
chr8_+_118428643 | 17.50 |
ENSMUST00000034304.9
|
Hsd17b2
|
hydroxysteroid (17-beta) dehydrogenase 2 |
chr10_+_127702326 | 17.44 |
ENSMUST00000092058.4
|
Rdh16f2
|
RDH16 family member 2 |
chr7_+_143027473 | 17.29 |
ENSMUST00000052348.12
|
Slc22a18
|
solute carrier family 22 (organic cation transporter), member 18 |
chr9_+_108216433 | 17.09 |
ENSMUST00000191997.2
|
Gpx1
|
glutathione peroxidase 1 |
chr16_+_22710027 | 16.99 |
ENSMUST00000231848.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr19_+_39980868 | 16.93 |
ENSMUST00000049178.3
|
Cyp2c37
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
chr14_-_30645711 | 16.93 |
ENSMUST00000006697.17
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr1_+_171052623 | 16.81 |
ENSMUST00000111321.8
ENSMUST00000005824.12 ENSMUST00000111320.8 ENSMUST00000111319.2 |
Apoa2
|
apolipoprotein A-II |
chr2_+_58645189 | 16.77 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr8_-_93956143 | 16.72 |
ENSMUST00000176282.2
ENSMUST00000034173.14 |
Ces1e
|
carboxylesterase 1E |
chr11_+_7147779 | 16.69 |
ENSMUST00000020704.8
|
Igfbp1
|
insulin-like growth factor binding protein 1 |
chr17_-_35081129 | 16.55 |
ENSMUST00000154526.8
|
Cfb
|
complement factor B |
chr5_-_115109118 | 16.51 |
ENSMUST00000031535.12
|
Hnf1a
|
HNF1 homeobox A |
chr17_-_35081456 | 16.29 |
ENSMUST00000025229.11
ENSMUST00000176203.9 ENSMUST00000128767.8 |
Cfb
|
complement factor B |
chr15_+_98997293 | 16.27 |
ENSMUST00000061295.7
|
Dnajc22
|
DnaJ heat shock protein family (Hsp40) member C22 |
chr8_+_13076024 | 16.26 |
ENSMUST00000033820.4
|
F7
|
coagulation factor VII |
chr9_+_108216233 | 16.23 |
ENSMUST00000082429.8
|
Gpx1
|
glutathione peroxidase 1 |
chr4_-_62005498 | 16.17 |
ENSMUST00000107488.4
ENSMUST00000107472.8 ENSMUST00000084531.11 |
Mup3
|
major urinary protein 3 |
chr11_+_16702203 | 16.02 |
ENSMUST00000102884.10
ENSMUST00000020329.13 |
Egfr
|
epidermal growth factor receptor |
chr12_-_103796632 | 15.88 |
ENSMUST00000164454.3
|
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chrX_+_138701544 | 15.85 |
ENSMUST00000054889.4
|
Cldn2
|
claudin 2 |
chr7_+_100970435 | 15.70 |
ENSMUST00000210192.2
ENSMUST00000172630.8 |
Stard10
|
START domain containing 10 |
chr19_-_40175709 | 15.51 |
ENSMUST00000051846.13
|
Cyp2c70
|
cytochrome P450, family 2, subfamily c, polypeptide 70 |
chr11_+_69945157 | 15.25 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr11_+_120382666 | 15.17 |
ENSMUST00000026899.4
|
Slc25a10
|
solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10 |
chr14_-_30645503 | 15.04 |
ENSMUST00000227995.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr17_+_80434874 | 15.02 |
ENSMUST00000039205.11
|
Galm
|
galactose mutarotase |
chr3_+_89043440 | 14.96 |
ENSMUST00000047111.13
|
Pklr
|
pyruvate kinase liver and red blood cell |
chr2_-_91466739 | 14.89 |
ENSMUST00000111335.2
ENSMUST00000028681.15 |
F2
|
coagulation factor II |
chrX_+_59044796 | 14.86 |
ENSMUST00000033477.5
|
F9
|
coagulation factor IX |
chr12_-_103871146 | 14.78 |
ENSMUST00000074051.6
|
Serpina1c
|
serine (or cysteine) peptidase inhibitor, clade A, member 1C |
chr16_+_22739191 | 14.78 |
ENSMUST00000116625.10
|
Fetub
|
fetuin beta |
chr3_+_89043879 | 14.66 |
ENSMUST00000107482.10
ENSMUST00000127058.2 |
Pklr
|
pyruvate kinase liver and red blood cell |
chr10_+_127637015 | 14.61 |
ENSMUST00000071646.2
|
Rdh16
|
retinol dehydrogenase 16 |
chr11_-_5900019 | 14.60 |
ENSMUST00000102920.4
|
Gck
|
glucokinase |
chr9_-_106035308 | 14.55 |
ENSMUST00000159809.2
ENSMUST00000162562.2 ENSMUST00000036382.13 |
Glyctk
|
glycerate kinase |
chr4_-_107975701 | 13.99 |
ENSMUST00000149106.8
|
Scp2
|
sterol carrier protein 2, liver |
chr19_+_12610870 | 13.97 |
ENSMUST00000119960.2
|
Glyat
|
glycine-N-acyltransferase |
chr19_-_39637489 | 13.88 |
ENSMUST00000067328.7
|
Cyp2c67
|
cytochrome P450, family 2, subfamily c, polypeptide 67 |
chr8_+_60958931 | 13.88 |
ENSMUST00000079472.4
|
Aadat
|
aminoadipate aminotransferase |
chr4_-_63072367 | 13.86 |
ENSMUST00000030041.5
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr5_-_89583469 | 13.82 |
ENSMUST00000200534.2
|
Gc
|
vitamin D binding protein |
chr10_+_18720760 | 13.80 |
ENSMUST00000019998.9
|
Perp
|
PERP, TP53 apoptosis effector |
chr10_-_25412010 | 13.77 |
ENSMUST00000179685.3
|
Smlr1
|
small leucine-rich protein 1 |
chr2_-_25391729 | 13.76 |
ENSMUST00000015227.4
|
C8g
|
complement component 8, gamma polypeptide |
chr11_+_120421496 | 13.72 |
ENSMUST00000026119.8
|
Gcgr
|
glucagon receptor |
chr15_-_78352801 | 13.67 |
ENSMUST00000229124.2
ENSMUST00000230226.2 ENSMUST00000017086.5 |
Tmprss6
|
transmembrane serine protease 6 |
chr9_+_106324952 | 13.64 |
ENSMUST00000215475.2
ENSMUST00000187106.7 ENSMUST00000190167.7 |
Abhd14b
|
abhydrolase domain containing 14b |
chr2_-_27138347 | 13.54 |
ENSMUST00000139312.8
|
Sardh
|
sarcosine dehydrogenase |
chr10_-_127206300 | 13.53 |
ENSMUST00000026472.10
|
Inhbc
|
inhibin beta-C |
chr7_-_30672824 | 13.44 |
ENSMUST00000147431.2
ENSMUST00000098553.11 ENSMUST00000108116.10 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr12_+_84085136 | 13.38 |
ENSMUST00000021652.5
|
Acot4
|
acyl-CoA thioesterase 4 |
chr11_+_115353290 | 13.38 |
ENSMUST00000106532.4
ENSMUST00000092445.12 ENSMUST00000153466.2 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr4_-_61592331 | 13.31 |
ENSMUST00000098040.4
|
Mup18
|
major urinary protein 18 |
chr11_-_59927688 | 13.30 |
ENSMUST00000102692.10
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr1_+_172525613 | 13.27 |
ENSMUST00000038495.5
|
Crp
|
C-reactive protein, pentraxin-related |
chr1_+_171041583 | 13.26 |
ENSMUST00000111328.8
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr7_-_19410749 | 13.25 |
ENSMUST00000003074.16
|
Apoc2
|
apolipoprotein C-II |
chr8_-_41668182 | 13.20 |
ENSMUST00000034003.5
|
Fgl1
|
fibrinogen-like protein 1 |
chr3_+_122039206 | 13.17 |
ENSMUST00000029769.14
|
Gclm
|
glutamate-cysteine ligase, modifier subunit |
chr9_-_121745354 | 13.11 |
ENSMUST00000062474.5
|
Cyp8b1
|
cytochrome P450, family 8, subfamily b, polypeptide 1 |
chr8_+_13087292 | 13.07 |
ENSMUST00000063820.12
ENSMUST00000033821.11 |
F10
|
coagulation factor X |
chr15_-_82648376 | 13.03 |
ENSMUST00000055721.6
|
Cyp2d40
|
cytochrome P450, family 2, subfamily d, polypeptide 40 |
chr9_+_46151994 | 13.02 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr7_-_30672747 | 12.91 |
ENSMUST00000205961.2
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr16_-_38115172 | 12.87 |
ENSMUST00000023504.5
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr17_+_35780977 | 12.79 |
ENSMUST00000174525.8
ENSMUST00000068291.7 |
H2-Q10
|
histocompatibility 2, Q region locus 10 |
chr16_+_22877000 | 12.76 |
ENSMUST00000039492.14
ENSMUST00000023589.15 ENSMUST00000089902.8 |
Kng1
|
kininogen 1 |
chr9_+_74769166 | 12.74 |
ENSMUST00000056006.11
|
Onecut1
|
one cut domain, family member 1 |
chr12_-_81014849 | 12.73 |
ENSMUST00000095572.5
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr17_-_46749370 | 12.62 |
ENSMUST00000087012.7
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr13_-_41373638 | 12.61 |
ENSMUST00000117096.2
|
Elovl2
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2 |
chr7_-_30672889 | 12.56 |
ENSMUST00000001279.15
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr15_-_82291372 | 12.50 |
ENSMUST00000230198.2
ENSMUST00000230248.2 ENSMUST00000072776.5 ENSMUST00000229911.2 |
Cyp2d10
|
cytochrome P450, family 2, subfamily d, polypeptide 10 |
chr4_-_104733580 | 12.47 |
ENSMUST00000064873.9
ENSMUST00000106808.10 ENSMUST00000048947.15 |
C8a
|
complement component 8, alpha polypeptide |
chr7_+_44114815 | 12.31 |
ENSMUST00000035929.11
ENSMUST00000146128.8 |
Aspdh
|
aspartate dehydrogenase domain containing |
chr7_+_123061535 | 12.23 |
ENSMUST00000098056.6
|
Aqp8
|
aquaporin 8 |
chr13_+_24054241 | 12.17 |
ENSMUST00000110413.8
|
Slc17a1
|
solute carrier family 17 (sodium phosphate), member 1 |
chr6_-_6217021 | 12.16 |
ENSMUST00000015256.15
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chr5_+_137568113 | 12.16 |
ENSMUST00000031729.13
ENSMUST00000199054.5 |
Tfr2
|
transferrin receptor 2 |
chr9_+_46179899 | 12.12 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr9_-_106035332 | 12.10 |
ENSMUST00000112543.9
|
Glyctk
|
glycerate kinase |
chr6_-_23132977 | 12.02 |
ENSMUST00000031707.14
|
Aass
|
aminoadipate-semialdehyde synthase |
chr18_+_87774402 | 12.01 |
ENSMUST00000091776.7
|
Gm5096
|
predicted gene 5096 |
chr1_+_88034556 | 11.96 |
ENSMUST00000113137.2
|
Ugt1a6b
|
UDP glucuronosyltransferase 1 family, polypeptide A6B |
chr11_-_75329726 | 11.94 |
ENSMUST00000108437.8
|
Serpinf2
|
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
chr10_+_127595639 | 11.91 |
ENSMUST00000128247.2
|
Rdh16f1
|
RDH16 family member 1 |
chr1_+_74752710 | 11.91 |
ENSMUST00000027356.7
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1 |
chr7_-_19415301 | 11.90 |
ENSMUST00000150569.9
ENSMUST00000127648.4 ENSMUST00000003071.10 |
Gm44805
Apoc4
|
predicted gene 44805 apolipoprotein C-IV |
chr15_+_31565508 | 11.86 |
ENSMUST00000226951.2
|
Cmbl
|
carboxymethylenebutenolidase-like (Pseudomonas) |
chr1_+_133291302 | 11.84 |
ENSMUST00000135222.9
|
Etnk2
|
ethanolamine kinase 2 |
chr1_+_160806241 | 11.82 |
ENSMUST00000195760.2
|
Serpinc1
|
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
chr19_-_8382424 | 11.77 |
ENSMUST00000064507.12
ENSMUST00000120540.2 ENSMUST00000096269.11 |
Slc22a30
|
solute carrier family 22, member 30 |
chr7_+_123061497 | 11.72 |
ENSMUST00000033023.10
|
Aqp8
|
aquaporin 8 |
chr16_-_18232202 | 11.65 |
ENSMUST00000165430.8
ENSMUST00000147720.3 |
Comt
|
catechol-O-methyltransferase |
chr4_+_45848918 | 11.65 |
ENSMUST00000030011.6
|
Stra6l
|
STRA6-like |
chr12_-_81014755 | 11.64 |
ENSMUST00000218342.2
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr7_+_100970910 | 11.61 |
ENSMUST00000174291.8
ENSMUST00000167888.9 ENSMUST00000172662.2 |
Stard10
|
START domain containing 10 |
chr9_-_103105638 | 11.57 |
ENSMUST00000126359.2
|
Trf
|
transferrin |
chr11_+_69983531 | 11.53 |
ENSMUST00000124721.2
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr6_-_83633064 | 11.40 |
ENSMUST00000014686.3
|
Clec4f
|
C-type lectin domain family 4, member f |
chr3_+_82933383 | 11.36 |
ENSMUST00000029630.15
ENSMUST00000166581.4 |
Fga
|
fibrinogen alpha chain |
chr6_-_6217126 | 11.36 |
ENSMUST00000188414.4
|
Slc25a13
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
chr4_+_45848816 | 11.30 |
ENSMUST00000107782.8
|
Stra6l
|
STRA6-like |
chr1_+_171041539 | 11.27 |
ENSMUST00000005820.11
ENSMUST00000075469.12 ENSMUST00000155126.8 |
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr9_+_108174052 | 11.27 |
ENSMUST00000035230.7
|
Amt
|
aminomethyltransferase |
chr14_+_55716197 | 11.25 |
ENSMUST00000022821.8
|
Dhrs4
|
dehydrogenase/reductase (SDR family) member 4 |
chr1_-_90897329 | 11.21 |
ENSMUST00000130042.2
ENSMUST00000027529.12 |
Rab17
|
RAB17, member RAS oncogene family |
chr10_-_76949510 | 11.20 |
ENSMUST00000105409.8
|
Col18a1
|
collagen, type XVIII, alpha 1 |
chr9_-_118986123 | 11.17 |
ENSMUST00000010795.5
|
Acaa1b
|
acetyl-Coenzyme A acyltransferase 1B |
chr11_+_69983479 | 11.15 |
ENSMUST00000143772.8
|
Asgr2
|
asialoglycoprotein receptor 2 |
chr10_+_62860291 | 11.14 |
ENSMUST00000020262.5
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr19_-_39729431 | 10.99 |
ENSMUST00000099472.4
|
Cyp2c68
|
cytochrome P450, family 2, subfamily c, polypeptide 68 |
chr1_+_175459559 | 10.95 |
ENSMUST00000040250.15
|
Kmo
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr10_+_62860094 | 10.95 |
ENSMUST00000124784.8
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr8_-_106863521 | 10.88 |
ENSMUST00000115979.9
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr1_+_93062962 | 10.87 |
ENSMUST00000027491.7
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr1_+_175459735 | 10.85 |
ENSMUST00000097458.4
|
Kmo
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr6_-_3988900 | 10.85 |
ENSMUST00000183682.3
|
Tfpi2
|
tissue factor pathway inhibitor 2 |
chr8_-_93806593 | 10.81 |
ENSMUST00000109582.3
|
Ces1b
|
carboxylesterase 1B |
chr4_-_60697274 | 10.81 |
ENSMUST00000117932.2
|
Mup12
|
major urinary protein 12 |
chr13_-_42001075 | 10.80 |
ENSMUST00000179758.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr12_-_103923145 | 10.78 |
ENSMUST00000085054.5
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chr17_+_35658131 | 10.77 |
ENSMUST00000071951.14
ENSMUST00000116598.10 ENSMUST00000078205.14 ENSMUST00000076256.8 |
H2-Q7
|
histocompatibility 2, Q region locus 7 |
chr10_+_128104525 | 10.69 |
ENSMUST00000050901.5
|
Apof
|
apolipoprotein F |
chr7_+_100970287 | 10.61 |
ENSMUST00000032927.14
|
Stard10
|
START domain containing 10 |
chr1_+_21310803 | 10.53 |
ENSMUST00000027067.15
|
Gsta3
|
glutathione S-transferase, alpha 3 |
chr17_+_85335775 | 10.52 |
ENSMUST00000024944.9
|
Slc3a1
|
solute carrier family 3, member 1 |
chr7_-_30814652 | 10.48 |
ENSMUST00000168884.8
ENSMUST00000108102.9 |
Hpn
|
hepsin |
chr5_-_87686048 | 10.36 |
ENSMUST00000031199.11
|
Sult1b1
|
sulfotransferase family 1B, member 1 |
chr5_-_137919873 | 10.27 |
ENSMUST00000031741.8
|
Cyp3a13
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
chr13_-_42001102 | 10.22 |
ENSMUST00000121404.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr11_-_59937302 | 10.20 |
ENSMUST00000000310.14
ENSMUST00000102693.9 ENSMUST00000148512.2 |
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr13_-_42000958 | 10.19 |
ENSMUST00000072012.10
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr14_+_14210394 | 10.15 |
ENSMUST00000164598.8
|
Acox2
|
acyl-Coenzyme A oxidase 2, branched chain |
chr19_-_8109346 | 10.12 |
ENSMUST00000065651.5
|
Slc22a28
|
solute carrier family 22, member 28 |
chr15_+_10358611 | 10.09 |
ENSMUST00000110541.8
ENSMUST00000110542.8 |
Agxt2
|
alanine-glyoxylate aminotransferase 2 |
chr8_+_105688344 | 10.00 |
ENSMUST00000043183.8
|
Ces2g
|
carboxylesterase 2G |
chr4_+_63262775 | 9.96 |
ENSMUST00000030044.3
|
Orm1
|
orosomucoid 1 |
chr6_+_48818567 | 9.94 |
ENSMUST00000203639.3
|
Tmem176a
|
transmembrane protein 176A |
chr11_+_73090270 | 9.93 |
ENSMUST00000006105.7
|
Shpk
|
sedoheptulokinase |
chr7_+_100971034 | 9.92 |
ENSMUST00000173270.8
|
Stard10
|
START domain containing 10 |
chr11_+_102036356 | 9.90 |
ENSMUST00000055409.6
|
Nags
|
N-acetylglutamate synthase |
chrX_-_84820209 | 9.86 |
ENSMUST00000142152.2
ENSMUST00000156390.8 |
Gk
|
glycerol kinase |
chr9_-_57590926 | 9.86 |
ENSMUST00000034860.5
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr3_-_10400710 | 9.77 |
ENSMUST00000078748.4
|
Slc10a5
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.1 | 45.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
14.2 | 56.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
13.0 | 38.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
12.7 | 50.9 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
11.8 | 35.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
9.9 | 29.6 | GO:0042853 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) |
9.0 | 27.0 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
7.6 | 22.9 | GO:0071939 | vitamin A transport(GO:0071938) vitamin A import(GO:0071939) |
7.4 | 88.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
7.2 | 28.9 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
6.8 | 33.8 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
6.6 | 26.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
6.6 | 19.8 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) |
6.4 | 44.7 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
5.6 | 28.1 | GO:0010958 | regulation of amino acid import(GO:0010958) L-arginine import(GO:0043091) arginine import(GO:0090467) |
5.6 | 22.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
5.4 | 87.0 | GO:0032782 | bile acid secretion(GO:0032782) |
5.3 | 16.0 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
5.2 | 31.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
5.0 | 19.9 | GO:0015811 | L-cystine transport(GO:0015811) |
4.9 | 82.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
4.9 | 53.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
4.8 | 9.7 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
4.8 | 14.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
4.8 | 33.5 | GO:0015886 | heme transport(GO:0015886) |
4.8 | 81.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
4.8 | 142.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
4.7 | 23.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
4.6 | 18.4 | GO:0015744 | succinate transport(GO:0015744) |
4.6 | 27.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
4.6 | 41.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
4.5 | 13.5 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
4.5 | 17.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
4.5 | 13.4 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
4.4 | 26.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
4.0 | 16.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
4.0 | 31.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.9 | 19.3 | GO:0006548 | histidine catabolic process(GO:0006548) |
3.8 | 22.7 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
3.8 | 11.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.7 | 11.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells(GO:0002414) |
3.7 | 14.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
3.7 | 14.9 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
3.7 | 18.3 | GO:1904970 | brush border assembly(GO:1904970) |
3.7 | 7.3 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
3.7 | 18.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
3.6 | 39.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
3.5 | 14.0 | GO:0032379 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
3.5 | 10.5 | GO:0034769 | basement membrane disassembly(GO:0034769) |
3.4 | 3.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
3.4 | 23.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
3.3 | 6.7 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.3 | 19.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
3.3 | 29.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
3.3 | 16.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
3.2 | 16.1 | GO:0034371 | chylomicron remodeling(GO:0034371) |
3.2 | 19.3 | GO:0039019 | pronephric nephron development(GO:0039019) |
3.2 | 16.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
3.2 | 9.6 | GO:0036343 | psychomotor behavior(GO:0036343) |
3.2 | 9.6 | GO:0060464 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) |
3.2 | 15.9 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
3.1 | 18.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
3.1 | 21.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.0 | 30.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
3.0 | 12.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.0 | 14.9 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
2.9 | 20.5 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
2.8 | 8.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
2.8 | 8.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.8 | 11.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.7 | 2.7 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
2.7 | 8.2 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
2.7 | 8.1 | GO:0046108 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
2.7 | 24.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.7 | 80.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
2.7 | 8.0 | GO:0015881 | creatine transport(GO:0015881) |
2.6 | 23.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
2.6 | 7.8 | GO:0006530 | asparagine catabolic process(GO:0006530) |
2.6 | 18.1 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.6 | 10.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.5 | 7.6 | GO:0018003 | peptidyl-lysine N6-acetylation(GO:0018003) |
2.5 | 32.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
2.5 | 53.9 | GO:0046415 | urate metabolic process(GO:0046415) |
2.4 | 7.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
2.4 | 11.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
2.3 | 11.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
2.3 | 11.7 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
2.3 | 16.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
2.3 | 11.5 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
2.3 | 6.9 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
2.2 | 20.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
2.2 | 6.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.2 | 6.7 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
2.2 | 8.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
2.2 | 28.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
2.1 | 21.3 | GO:0015747 | urate transport(GO:0015747) |
2.1 | 37.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
2.0 | 11.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.8 | 7.3 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.8 | 72.8 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
1.8 | 9.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.8 | 7.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.8 | 28.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.7 | 5.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
1.7 | 50.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.7 | 5.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.7 | 8.6 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
1.7 | 13.7 | GO:0033762 | response to glucagon(GO:0033762) |
1.7 | 15.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
1.7 | 3.3 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
1.6 | 9.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.6 | 8.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
1.6 | 13.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.6 | 3.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.6 | 6.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
1.5 | 4.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
1.5 | 7.5 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.5 | 17.9 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
1.5 | 4.5 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
1.5 | 4.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.5 | 5.9 | GO:0061386 | closure of optic fissure(GO:0061386) |
1.5 | 5.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.4 | 7.2 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
1.4 | 4.3 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
1.4 | 25.6 | GO:0017144 | drug metabolic process(GO:0017144) |
1.4 | 4.2 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
1.4 | 12.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.4 | 7.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.4 | 4.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.3 | 1.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.3 | 4.0 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
1.3 | 12.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.3 | 9.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.3 | 61.8 | GO:0006953 | acute-phase response(GO:0006953) |
1.3 | 3.9 | GO:0016125 | sterol metabolic process(GO:0016125) |
1.3 | 5.2 | GO:0030091 | protein repair(GO:0030091) |
1.3 | 3.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.3 | 8.9 | GO:0015862 | uridine transport(GO:0015862) |
1.3 | 6.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.3 | 17.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.2 | 4.9 | GO:0038163 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) |
1.2 | 17.0 | GO:0002934 | desmosome organization(GO:0002934) |
1.2 | 4.8 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.2 | 12.7 | GO:0042730 | fibrinolysis(GO:0042730) |
1.1 | 3.4 | GO:0031104 | dendrite regeneration(GO:0031104) |
1.1 | 4.5 | GO:0090472 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) dibasic protein processing(GO:0090472) |
1.1 | 3.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
1.1 | 12.0 | GO:0015879 | carnitine transport(GO:0015879) |
1.1 | 2.2 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
1.1 | 3.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.1 | 12.6 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.1 | 3.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.0 | 3.1 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
1.0 | 5.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
1.0 | 16.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.0 | 5.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.0 | 9.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.0 | 1.0 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
1.0 | 3.9 | GO:0090345 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
1.0 | 3.9 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
1.0 | 2.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.0 | 2.9 | GO:0060585 | ovarian follicle rupture(GO:0001543) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.0 | 5.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.9 | 16.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.9 | 2.7 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.9 | 9.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.9 | 6.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.9 | 32.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.9 | 9.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.9 | 10.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.9 | 4.4 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.9 | 3.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.9 | 6.8 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.8 | 2.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.8 | 3.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.8 | 2.4 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.8 | 15.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.8 | 1.6 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.8 | 4.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.8 | 8.0 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.8 | 43.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.8 | 1.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.8 | 3.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.8 | 1.6 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.8 | 7.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.8 | 5.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.8 | 6.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.8 | 4.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.8 | 9.1 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.8 | 4.5 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.7 | 3.7 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.7 | 5.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.7 | 8.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.7 | 8.0 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.7 | 9.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.7 | 2.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.7 | 1.4 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.7 | 2.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.7 | 5.8 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.7 | 0.7 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.7 | 7.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.7 | 2.8 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.7 | 5.7 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.7 | 4.2 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.7 | 34.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.7 | 1.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.7 | 31.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.7 | 2.1 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.7 | 1.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.7 | 2.1 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
0.7 | 2.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.7 | 14.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.7 | 11.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.7 | 2.6 | GO:0010286 | heat acclimation(GO:0010286) |
0.7 | 19.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.7 | 5.9 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.7 | 10.5 | GO:0051132 | NK T cell activation(GO:0051132) |
0.7 | 3.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.7 | 2.6 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.6 | 1.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.6 | 6.4 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.6 | 3.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.6 | 6.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.6 | 7.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.6 | 11.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.6 | 4.3 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 1.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.6 | 1.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.6 | 3.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 3.6 | GO:0071599 | otic vesicle development(GO:0071599) |
0.6 | 1.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.6 | 2.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.6 | 3.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.6 | 1.8 | GO:1904502 | sphinganine metabolic process(GO:0006667) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.6 | 7.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.6 | 2.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.6 | 2.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.6 | 8.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.6 | 5.7 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.6 | 3.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.6 | 2.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 10.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.5 | 1.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 2.7 | GO:0070383 | DNA cytosine deamination(GO:0070383) positive regulation of mRNA modification(GO:0090366) |
0.5 | 6.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 7.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.5 | 9.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.5 | 1.6 | GO:1990168 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 3.7 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.5 | 1.6 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.5 | 1.6 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.5 | 1.6 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.5 | 2.1 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 3.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.5 | 1.5 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.5 | 2.1 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.5 | 18.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.5 | 1.5 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.5 | 1.5 | GO:0009955 | adaxial/abaxial pattern specification(GO:0009955) regulation of adaxial/abaxial pattern formation(GO:2000011) |
0.5 | 1.5 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.5 | 3.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.5 | 23.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.5 | 6.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.5 | 6.0 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.5 | 1.5 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.5 | 4.0 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.5 | 7.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 3.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.5 | 1.9 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.5 | 2.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) positive regulation of somatostatin secretion(GO:0090274) |
0.5 | 10.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.5 | 3.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.5 | 2.8 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.5 | 1.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 4.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.5 | 16.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.5 | 6.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.4 | 1.8 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.4 | 9.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 1.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 2.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 13.3 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.4 | 1.3 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.4 | 4.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 12.1 | GO:0015893 | drug transport(GO:0015893) |
0.4 | 0.4 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.4 | 2.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 0.8 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 1.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 3.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.4 | 8.2 | GO:0071451 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.4 | 2.6 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 2.6 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 3.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 3.0 | GO:0098792 | xenophagy(GO:0098792) |
0.4 | 2.6 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.4 | 3.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.4 | 0.4 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.4 | 2.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 15.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.4 | 3.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.4 | 3.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 6.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 1.8 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.3 | 2.1 | GO:0050689 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 2.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.3 | 4.9 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 1.7 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.3 | 11.4 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.3 | 9.6 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 5.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 8.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 1.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 7.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.3 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 3.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 4.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.3 | 9.2 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.3 | 2.3 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.3 | 7.9 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 18.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 6.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 32.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.3 | 4.8 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 1.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.3 | 4.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 2.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 1.5 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.3 | 1.2 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.3 | 3.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.3 | 2.7 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 4.8 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 0.6 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.3 | 0.9 | GO:0035037 | sperm entry(GO:0035037) |
0.3 | 0.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 0.6 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
0.3 | 1.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 1.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 2.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 5.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 1.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 1.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.3 | 12.7 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.3 | 0.8 | GO:0010511 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) regulation of phosphatidylinositol biosynthetic process(GO:0010511) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.3 | 1.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 1.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 5.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 1.4 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 3.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 1.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 1.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 6.9 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.3 | 2.6 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 1.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 1.8 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.3 | 1.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 3.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 1.5 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.3 | 1.5 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.3 | 4.3 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.3 | 1.3 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.2 | 1.0 | GO:1902396 | positive regulation of pinocytosis(GO:0048549) protein localization to bicellular tight junction(GO:1902396) |
0.2 | 1.7 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.7 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 2.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 3.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.9 | GO:0045006 | DNA deamination(GO:0045006) |
0.2 | 2.6 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 10.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 3.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 3.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.2 | 1.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 1.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 1.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.2 | 0.9 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 6.5 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 1.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 4.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 2.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.8 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 1.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.6 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 3.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 7.4 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.2 | 1.4 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.2 | 1.6 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 1.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 9.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 1.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 1.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 2.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 3.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 1.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.2 | 1.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 3.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 1.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 2.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 1.0 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 3.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 2.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.2 | 0.8 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 3.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 23.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.2 | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 4.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.2 | 0.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 1.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.2 | 0.3 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.2 | 0.3 | GO:0048819 | negative regulation of hair follicle maturation(GO:0048817) regulation of hair follicle maturation(GO:0048819) |
0.2 | 2.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 1.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 2.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 3.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.2 | 1.7 | GO:0098789 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 7.5 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.2 | 0.6 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 1.9 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 1.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 10.0 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 2.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 3.0 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 3.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 4.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 6.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 1.3 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 7.9 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 1.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 1.6 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.4 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.1 | 1.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 4.0 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 1.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 1.2 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 8.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 2.2 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 1.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 1.0 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 2.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.5 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 1.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 15.6 | GO:0009636 | response to toxic substance(GO:0009636) |
0.1 | 2.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.5 | GO:0017126 | nucleologenesis(GO:0017126) |
0.1 | 1.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 1.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 1.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.3 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.1 | 0.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 4.5 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 1.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 2.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 1.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 1.6 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.9 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 1.4 | GO:0061037 | negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
0.1 | 0.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 1.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 1.0 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.1 | 1.1 | GO:0035813 | regulation of renal sodium excretion(GO:0035813) |
0.1 | 3.9 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 1.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 1.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 1.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 5.0 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 1.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 1.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 6.2 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 3.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 1.8 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.7 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 4.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 5.3 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 1.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 1.9 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 1.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 3.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 2.1 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.1 | 3.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 2.8 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.9 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 3.6 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.1 | 2.7 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.1 | 0.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 8.0 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 1.0 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 1.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 1.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.7 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.2 | GO:0035482 | gastric motility(GO:0035482) |
0.0 | 0.6 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.5 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.0 | 0.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.0 | 2.5 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.0 | 1.3 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.0 | 0.3 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 1.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.8 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.4 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.0 | 1.6 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.9 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.0 | 0.5 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.0 | 0.2 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 1.0 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 7.4 | GO:0043434 | response to peptide hormone(GO:0043434) |
0.0 | 1.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 2.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 4.2 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.5 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 18.1 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.2 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 1.2 | GO:0001942 | hair follicle development(GO:0001942) skin epidermis development(GO:0098773) |
0.0 | 0.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.5 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 1.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.0 | 0.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 1.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.2 | GO:0060993 | kidney morphogenesis(GO:0060993) |
0.0 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.3 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.5 | 70.4 | GO:0034359 | mature chylomicron(GO:0034359) |
8.7 | 69.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
7.3 | 21.9 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
6.9 | 55.3 | GO:0097413 | Lewy body(GO:0097413) |
6.7 | 80.9 | GO:0042627 | chylomicron(GO:0042627) |
5.5 | 22.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
5.0 | 44.8 | GO:0005579 | membrane attack complex(GO:0005579) |
3.9 | 19.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.6 | 65.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
3.0 | 39.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.8 | 83.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
2.8 | 11.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
2.7 | 34.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.6 | 28.9 | GO:0031983 | vesicle lumen(GO:0031983) |
2.6 | 23.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.5 | 7.6 | GO:0005715 | late recombination nodule(GO:0005715) |
2.4 | 23.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
2.1 | 14.9 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.8 | 19.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.7 | 5.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
1.5 | 29.3 | GO:0045180 | basal cortex(GO:0045180) |
1.5 | 9.0 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
1.4 | 11.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.4 | 1.4 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
1.3 | 19.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.2 | 3.7 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
1.1 | 3.3 | GO:0031477 | stereocilia tip link(GO:0002140) myosin VII complex(GO:0031477) stereocilia tip-link density(GO:1990427) upper tip-link density(GO:1990435) |
1.1 | 26.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.0 | 3.1 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
1.0 | 3.9 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.0 | 7.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.9 | 232.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.9 | 3.5 | GO:1990429 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.9 | 8.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.9 | 184.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.8 | 7.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.8 | 4.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.8 | 2.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.7 | 3.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.7 | 86.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.7 | 11.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 3.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 3.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 4.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.6 | 1.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.6 | 1.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.6 | 3.3 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 2.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.5 | 9.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 4.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 6.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.5 | 8.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 2.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.5 | 2.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.5 | 49.1 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 11.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.5 | 98.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.4 | 4.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 3.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 14.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.4 | 4.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 6.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 10.6 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 10.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.4 | 5.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 3.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 4.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.4 | 12.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.4 | 1.8 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 11.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.1 | GO:0001652 | granular component(GO:0001652) |
0.3 | 20.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 4.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 1.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 2.5 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 4.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 2.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 2.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 1.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 3.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 3.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 3.0 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.3 | 79.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.3 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 32.1 | GO:0005903 | brush border(GO:0005903) |
0.3 | 4.5 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.3 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.6 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 118.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 4.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 2.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 3.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 11.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 4.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.7 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 0.7 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 0.9 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.2 | 0.6 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 8.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 2.0 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 3.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 29.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 12.6 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 1.7 | GO:0000801 | central element(GO:0000801) |
0.2 | 1.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 1.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 321.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 38.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 1.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 4.0 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 1.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.9 | GO:0070449 | elongin complex(GO:0070449) |
0.2 | 177.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 4.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 5.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 1.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 3.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 10.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 1.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 6.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 3.9 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 2.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 2.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 136.4 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 1.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 8.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 2.1 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 1.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.7 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 2.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 5.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 1.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 1.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 5.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.3 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 25.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.4 | GO:0031901 | early endosome membrane(GO:0031901) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.4 | 73.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
14.1 | 84.9 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
9.4 | 37.8 | GO:0018455 | alcohol dehydrogenase [NAD(P)+] activity(GO:0018455) |
9.0 | 27.0 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
8.8 | 26.5 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
8.5 | 34.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
8.2 | 24.5 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
7.9 | 103.1 | GO:0035473 | lipase binding(GO:0035473) |
7.8 | 31.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
7.4 | 22.3 | GO:0008431 | vitamin E binding(GO:0008431) |
7.3 | 21.9 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
6.7 | 40.5 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
6.0 | 36.1 | GO:0015232 | heme transporter activity(GO:0015232) |
5.5 | 22.0 | GO:0005118 | sevenless binding(GO:0005118) |
5.5 | 27.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
5.5 | 32.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
5.3 | 26.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
5.3 | 15.8 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
5.3 | 5.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
5.0 | 25.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
5.0 | 19.9 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
4.9 | 29.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
4.7 | 52.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
4.7 | 23.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
4.6 | 27.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
4.6 | 13.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
4.5 | 13.5 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
4.4 | 39.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
4.3 | 34.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
4.3 | 21.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
4.2 | 16.9 | GO:1902271 | D3 vitamins binding(GO:1902271) |
4.1 | 16.3 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
4.0 | 16.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
4.0 | 16.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
3.9 | 59.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
3.9 | 3.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
3.9 | 106.1 | GO:0070330 | aromatase activity(GO:0070330) |
3.9 | 11.7 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
3.8 | 19.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
3.7 | 7.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
3.7 | 18.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
3.6 | 25.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
3.6 | 18.1 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
3.5 | 21.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
3.5 | 14.0 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
3.5 | 10.4 | GO:0035478 | chylomicron binding(GO:0035478) |
3.5 | 13.9 | GO:0019862 | IgA binding(GO:0019862) |
3.4 | 33.8 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
3.4 | 23.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
3.3 | 13.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
3.3 | 13.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
3.1 | 9.4 | GO:0004454 | ketohexokinase activity(GO:0004454) |
3.1 | 9.3 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
3.1 | 18.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
3.0 | 12.0 | GO:0004103 | choline kinase activity(GO:0004103) |
2.9 | 20.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.9 | 23.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.9 | 11.6 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
2.9 | 8.6 | GO:0050354 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
2.9 | 14.4 | GO:0070287 | ferritin receptor activity(GO:0070287) |
2.8 | 22.8 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
2.8 | 8.3 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
2.7 | 8.1 | GO:0033971 | hydroxyisourate hydrolase activity(GO:0033971) |
2.7 | 8.0 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
2.6 | 7.9 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
2.6 | 7.8 | GO:0004067 | asparaginase activity(GO:0004067) |
2.6 | 18.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
2.5 | 60.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
2.5 | 27.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
2.5 | 14.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.5 | 42.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
2.4 | 7.3 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
2.4 | 16.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
2.3 | 6.9 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
2.3 | 6.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
2.3 | 9.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
2.2 | 62.5 | GO:0001848 | complement binding(GO:0001848) |
2.2 | 6.6 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
2.2 | 6.6 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
2.2 | 4.4 | GO:0038132 | neuregulin binding(GO:0038132) |
2.2 | 2.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
2.2 | 4.3 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.1 | 23.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.1 | 14.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
2.1 | 35.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
2.1 | 35.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
2.0 | 20.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.0 | 6.0 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
2.0 | 13.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
2.0 | 13.9 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
2.0 | 9.9 | GO:0034618 | arginine binding(GO:0034618) |
1.9 | 30.3 | GO:0015250 | water channel activity(GO:0015250) |
1.9 | 58.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.9 | 5.6 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
1.8 | 12.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
1.8 | 23.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.8 | 18.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.8 | 5.4 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
1.7 | 5.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
1.7 | 20.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.7 | 37.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.7 | 5.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.7 | 6.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.7 | 6.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.7 | 15.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.7 | 11.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
1.7 | 8.3 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
1.6 | 4.9 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
1.6 | 6.3 | GO:0042806 | fucose binding(GO:0042806) |
1.6 | 48.6 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
1.5 | 21.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
1.5 | 5.9 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.5 | 49.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
1.5 | 4.4 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
1.5 | 7.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.4 | 20.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.4 | 10.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.4 | 25.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.4 | 40.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
1.4 | 19.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.3 | 8.1 | GO:0070404 | NADH binding(GO:0070404) |
1.3 | 4.0 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
1.3 | 11.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.3 | 3.8 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
1.2 | 191.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.2 | 3.5 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
1.1 | 3.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.1 | 6.6 | GO:0032810 | sterol response element binding(GO:0032810) |
1.1 | 8.6 | GO:0005124 | scavenger receptor binding(GO:0005124) |
1.1 | 4.2 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
1.1 | 12.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.0 | 9.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.0 | 25.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
1.0 | 20.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.0 | 11.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
1.0 | 3.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.0 | 3.9 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.0 | 2.9 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
1.0 | 3.9 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.0 | 4.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.0 | 9.6 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.9 | 5.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.9 | 2.8 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.9 | 33.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.9 | 10.3 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 4.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.9 | 7.1 | GO:0005534 | galactose binding(GO:0005534) |
0.9 | 205.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.9 | 2.6 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.9 | 5.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.9 | 5.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.8 | 16.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.8 | 3.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.8 | 6.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.8 | 1.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.8 | 3.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.8 | 3.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.8 | 11.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.8 | 3.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.8 | 8.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 4.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
0.7 | 2.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.7 | 14.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.7 | 4.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.7 | 21.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.7 | 4.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 4.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 2.0 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.7 | 3.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.6 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.7 | 2.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 3.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 9.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 3.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.6 | 4.3 | GO:0002135 | CTP binding(GO:0002135) |
0.6 | 1.2 | GO:0033265 | choline binding(GO:0033265) |
0.6 | 15.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 3.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.6 | 3.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 14.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.6 | 5.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 4.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.6 | 24.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 6.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 2.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 4.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 2.8 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.6 | 9.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.6 | 3.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 2.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.5 | 1.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 2.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.5 | 2.7 | GO:0004131 | cytosine deaminase activity(GO:0004131) |
0.5 | 3.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 3.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 7.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.5 | 6.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.5 | 2.0 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.5 | 1.5 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.5 | 3.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.5 | 4.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 1.4 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.5 | 7.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 1.9 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.5 | 12.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 2.8 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.5 | 1.4 | GO:0070122 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.5 | 1.8 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.5 | 9.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.5 | 2.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 19.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.5 | 7.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 1.4 | GO:0071820 | N-box binding(GO:0071820) |
0.5 | 3.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.4 | 5.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.4 | 7.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 1.3 | GO:0047598 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.4 | 2.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.3 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.4 | 1.2 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.4 | 12.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 2.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 4.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 10.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 1.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 5.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 2.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.4 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 4.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 2.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 2.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 3.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 1.4 | GO:0070976 | TIR domain binding(GO:0070976) |
0.4 | 1.8 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.3 | 2.8 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 3.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 43.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.3 | 3.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 8.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 2.9 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 1.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 5.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 1.3 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.3 | 2.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 5.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 12.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.3 | 6.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 0.9 | GO:0016419 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) phosphopantetheine binding(GO:0031177) |
0.3 | 0.3 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.3 | 11.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.3 | 43.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.3 | 1.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.3 | 6.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 5.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 0.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 4.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 4.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.3 | 23.6 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.3 | 2.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 2.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 2.7 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 2.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 7.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 1.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 14.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 12.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 2.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 2.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 2.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 2.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 1.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 3.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 1.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 2.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.7 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.2 | 0.6 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.2 | 2.1 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.9 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.2 | 0.6 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 3.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.7 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 6.3 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.2 | 9.4 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 1.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 18.0 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.2 | 11.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 1.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 2.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 12.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 2.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 24.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 6.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 8.3 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.6 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 0.5 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.2 | 1.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.2 | 8.0 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 1.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.6 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.1 | 1.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.3 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 4.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 3.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 6.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 1.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 1.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 2.7 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 2.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 30.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 8.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.4 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 1.0 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 10.6 | GO:0016853 | isomerase activity(GO:0016853) |
0.1 | 0.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 1.5 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 1.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 3.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 1.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 2.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 1.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 3.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 3.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 1.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 5.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 4.7 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 14.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 3.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 3.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 3.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.1 | 3.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.0 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 3.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 5.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.0 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0070773 | protein-N-terminal glutamine amidohydrolase activity(GO:0070773) |
0.0 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 1.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 1.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.0 | 1.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 1.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 2.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 1.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 5.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 5.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 188.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.3 | 73.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.3 | 79.0 | PID BMP PATHWAY | BMP receptor signaling |
1.1 | 7.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.9 | 23.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.9 | 27.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 1.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.7 | 189.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 11.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 16.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 30.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 3.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 19.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 27.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 17.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 11.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 2.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.3 | 15.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 6.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 22.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 20.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 4.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 15.1 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 17.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 7.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 9.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 3.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 4.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 2.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 4.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 17.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 7.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 10.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 3.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 3.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 179.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
5.8 | 81.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
4.6 | 32.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
3.9 | 42.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.7 | 51.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
3.3 | 9.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
3.2 | 96.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
3.1 | 106.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
3.0 | 57.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
3.0 | 11.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.9 | 49.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
2.9 | 46.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.8 | 52.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
2.6 | 44.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
2.6 | 49.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.4 | 28.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.2 | 77.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
2.0 | 8.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.9 | 27.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.8 | 37.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.5 | 27.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.4 | 111.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
1.3 | 26.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.3 | 16.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.3 | 5.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
1.3 | 3.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.2 | 13.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.0 | 22.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.9 | 61.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.9 | 37.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.9 | 27.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.8 | 168.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.8 | 44.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.8 | 1.6 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.8 | 25.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 14.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.7 | 19.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.7 | 11.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 21.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.7 | 34.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.7 | 11.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 9.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 1.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.6 | 21.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 4.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.5 | 13.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.5 | 6.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.5 | 5.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 19.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.5 | 10.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 4.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.5 | 4.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 9.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 42.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 28.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 5.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 47.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.4 | 27.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 3.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 7.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.4 | 6.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 6.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 18.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 3.7 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 5.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 3.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 1.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 6.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 4.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 5.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 4.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 4.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 8.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 4.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 4.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 4.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 1.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 1.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 2.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 7.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 6.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 1.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 8.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.2 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.1 | 9.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 1.4 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 1.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 3.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 2.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 4.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 3.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 3.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 2.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 1.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 1.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.6 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.8 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |